Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASCL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SAMD14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFLAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928443 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MEOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NETO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNRC18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RECQL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on